Neuronetics Inc (STIM)

$3.40 +0.02 (0.59%)
Market Cap 223.50M
Revenue (ttm) 74.89M
Net Income (ttm) -43.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -58.37%
Debt to Equity Ratio 1.76
Volume 1,903,400
Avg Vol 1,135,906
Day's Range N/A - N/A
Shares Out 66.13M
Stochastic %K 25%
Beta 1.78
Analysts Strong Sell
Price Target $6.50

Company Profile

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific area...

Industry: Medical Devices
Sector: Healthcare
Phone: 610 640 4202
Fax: 610 640 4206
Address:
3222 Phoenixville Pike, Malvern, United States
mhaven2020
mhaven2020 Aug. 12 at 3:59 PM
$STIM closedsome here and $PAPL. Hopped in $BTBT and $ELDN for a few days. Want the alerts? Sign up through paypal in the catalog on our site. $2.99 per month gets 4 solid tickers a day that are a few days away from their move. Stop being late to the party!
0 · Reply
mhaven2020
mhaven2020 Aug. 11 at 11:06 AM
$STIM hello beautiful! $PAPL
0 · Reply
BioGem
BioGem Aug. 9 at 3:16 PM
$STIM Took a short on the strange pump after earning in the mid $4. Many critical issues: -While they kept the same revenue guidance, they applied a huge down guidance to their gross margins and increased significantly their future operating expenses = a lot more operating losses to be expected in 2025. -They pushed their ability to be cash flow positive further out. -Cash is too low at 11M in June = more debt and dilutions from the ATM are a certainty. -Heavy and expensive debt is already sitting on the balance sheet. -Current liabilities are increasing every quarter. -High short interest and analysts dropped their price targets.
0 · Reply
JarvisFlow
JarvisFlow Aug. 6 at 6:13 PM
Canaccord Genuity updates rating for Neuronetics ( $STIM ) to Buy, target set at 8 → 7.
0 · Reply
Shlobby
Shlobby Aug. 5 at 4:13 PM
Missed $UMAC this morning the. Caught dip at 10.30. Full position now. Cut a few $LC $STIM. Also added $GOGL
0 · Reply
HaltTradeAlert
HaltTradeAlert Aug. 5 at 3:35 PM
$STIM Halt Time: 11:33:54 Issue Symbol: STIM Reason Code: LUDP Members get this halt alert with no delay and with more info: last stock price, volume, shares outstanding, market cap, relative volume, and percentage change on the day. Also, halt alerts for pre-market hours and after market hours which is extremely important for Code T1 News Pending Alerts!! And free real time news catalyst alerts!
0 · Reply
_www_larval_com_
_www_larval_com_ Aug. 5 at 3:32 PM
$STIM has reverted 4% higher to -8% (~2Mv) in the last few minutes, 08/15 options, follow for more volatility.
0 · Reply
Shlobby
Shlobby Jul. 30 at 1:48 PM
Also opened $STIM
0 · Reply
dln101
dln101 Jul. 24 at 12:26 PM
$CLGN slow and steady back above $4-5, similar to $IRBT $STIM $ALDX $SATL 🤔💪🔥🚀
0 · Reply
PhaseFlow
PhaseFlow Jul. 23 at 3:22 AM
$STIM Looking for $4.75-5.00. If it makes it to $5 and breaks above then nothing to stop it until $7.00 Short term looking for about 15% move on this
0 · Reply
Latest News on STIM
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Aug 6, 2025, 4:45 PM EDT - 16 days ago

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Neuronetics, Inc. (STIM) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 12:53 PM EDT - 17 days ago

Neuronetics, Inc. (STIM) Q2 2025 Earnings Call Transcript

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

Aug 4, 2025, 4:30 PM EDT - 18 days ago

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

Jul 30, 2025, 8:32 AM EDT - 23 days ago

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

Neuronetics Appoints New Chief Financial Officer

Jul 15, 2025, 7:30 AM EDT - 5 weeks ago

Neuronetics Appoints New Chief Financial Officer

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program

Jun 10, 2025, 8:31 AM EDT - 2 months ago

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program

Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes

Jun 2, 2025, 4:30 PM EDT - 2 months ago

Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes

Neuronetics, Inc. (STIM) Q1 2025 Earnings Call Transcript

May 6, 2025, 9:57 AM EDT - 3 months ago

Neuronetics, Inc. (STIM) Q1 2025 Earnings Call Transcript

Neuronetics Reports First Quarter 2025 Financial and Operating Results

May 6, 2025, 7:10 AM EDT - 3 months ago

Neuronetics Reports First Quarter 2025 Financial and Operating Results

Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression

Mar 31, 2025, 8:31 AM EDT - 5 months ago

Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression

Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs

Mar 29, 2025, 11:45 PM EDT - 5 months ago

Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs

Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results

Mar 27, 2025, 4:30 PM EDT - 5 months ago

Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results

Neuronetics, Inc. (STIM) Q4 2024 Earnings Call Transcript

Mar 4, 2025, 9:52 AM EST - 6 months ago

Neuronetics, Inc. (STIM) Q4 2024 Earnings Call Transcript

Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Mar 4, 2025, 7:10 AM EST - 6 months ago

Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock

Feb 7, 2025, 7:54 AM EST - 7 months ago

Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock

Neuronetics Announces Launch of Underwritten Public Offering of Common Stock

Feb 6, 2025, 4:23 PM EST - 7 months ago

Neuronetics Announces Launch of Underwritten Public Offering of Common Stock

NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression

Jan 29, 2025, 8:31 AM EST - 7 months ago

NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression

Neuronetics and Greenbrook TMS Announce Closing of Transaction

Dec 10, 2024, 10:00 AM EST - 9 months ago

Neuronetics and Greenbrook TMS Announce Closing of Transaction

Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 8:30 AM EST - 9 months ago

Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference

Neuronetics, Inc. (STIM) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 8:41 PM EST - 10 months ago

Neuronetics, Inc. (STIM) Q3 2024 Earnings Call Transcript

CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

Nov 12, 2024, 6:45 PM EST - 10 months ago

CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

Nov 12, 2024, 7:10 AM EST - 10 months ago

Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call

Oct 29, 2024, 4:30 PM EDT - 10 months ago

Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call

NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression

Oct 14, 2024, 8:31 AM EDT - 11 months ago

NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression

Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings

Oct 4, 2024, 8:33 AM EDT - 11 months ago

Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings

Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents

Sep 25, 2024, 8:31 AM EDT - 11 months ago

Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents

Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults

Sep 19, 2024, 8:31 AM EDT - 1 year ago

Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults

NeuroStar® Releases Software Upgrades to Elevate Patient Care

Sep 16, 2024, 8:32 AM EDT - 1 year ago

NeuroStar® Releases Software Upgrades to Elevate Patient Care

NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories

Sep 3, 2024, 8:29 AM EDT - 1 year ago

NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories

Neuronetics, Inc. (STIM) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 1:59 PM EDT - 1 year ago

Neuronetics, Inc. (STIM) Q2 2024 Earnings Call Transcript

Noninvasive Treatment Provider Neuronetics Agrees To Merge With Canadian Firm Greenbrook TMS; Reports Q2 Earnings And Guidance Below Expectations

Aug 12, 2024, 1:12 PM EDT - 1 year ago

Noninvasive Treatment Provider Neuronetics Agrees To Merge With Canadian Firm Greenbrook TMS; Reports Q2 Earnings And Guidance Below Expectations

Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge

Aug 12, 2024, 7:15 AM EDT - 1 year ago

Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge

Neuronetics Reports Record Second Quarter 2024 Financial and Operating Results

Aug 12, 2024, 7:10 AM EDT - 1 year ago

Neuronetics Reports Record Second Quarter 2024 Financial and Operating Results

NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month

Aug 1, 2024, 8:29 AM EDT - 1 year ago

NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month

Neuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive Advisors

Jul 30, 2024, 8:30 AM EDT - 1 year ago

Neuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive Advisors

Neuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call

Jul 29, 2024, 8:30 AM EDT - 1 year ago

Neuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call

Aetna Policy Update Expands TMS Availability for Adolescents With Depression

Jul 22, 2024, 8:31 AM EDT - 1 year ago

Aetna Policy Update Expands TMS Availability for Adolescents With Depression

California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults

Jul 11, 2024, 8:36 AM EDT - 1 year ago

California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults

BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents

Jul 10, 2024, 8:32 AM EDT - 1 year ago

BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents

NeuroStar® Launches Better Me Provider Program Nationwide

Jul 1, 2024, 8:02 AM EDT - 1 year ago

NeuroStar® Launches Better Me Provider Program Nationwide

NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting

Jun 13, 2024, 8:31 AM EDT - 1 year ago

NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting

Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference

May 23, 2024, 8:30 AM EDT - 1 year ago

Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference

Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents

May 15, 2024, 7:32 AM EDT - 1 year ago

Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents

Neuronetics, Inc. (STIM) Q1 2024 Earnings Call Transcript

May 7, 2024, 5:16 PM EDT - 1 year ago

Neuronetics, Inc. (STIM) Q1 2024 Earnings Call Transcript

Neuronetics Reports Record First Quarter 2024 Financial and Operating Results

May 7, 2024, 7:30 AM EDT - 1 year ago

Neuronetics Reports Record First Quarter 2024 Financial and Operating Results

NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month

May 1, 2024, 8:31 AM EDT - 1 year ago

NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month

Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call

Apr 23, 2024, 4:30 PM EDT - 1 year ago

Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call

New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital

Apr 10, 2024, 8:31 AM EDT - 1 year ago

New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital

NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression

Mar 25, 2024, 8:30 AM EDT - 1 year ago

NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression

Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network

Mar 7, 2024, 8:22 AM EST - 1 year ago

Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network

mhaven2020
mhaven2020 Aug. 12 at 3:59 PM
$STIM closedsome here and $PAPL. Hopped in $BTBT and $ELDN for a few days. Want the alerts? Sign up through paypal in the catalog on our site. $2.99 per month gets 4 solid tickers a day that are a few days away from their move. Stop being late to the party!
0 · Reply
mhaven2020
mhaven2020 Aug. 11 at 11:06 AM
$STIM hello beautiful! $PAPL
0 · Reply
BioGem
BioGem Aug. 9 at 3:16 PM
$STIM Took a short on the strange pump after earning in the mid $4. Many critical issues: -While they kept the same revenue guidance, they applied a huge down guidance to their gross margins and increased significantly their future operating expenses = a lot more operating losses to be expected in 2025. -They pushed their ability to be cash flow positive further out. -Cash is too low at 11M in June = more debt and dilutions from the ATM are a certainty. -Heavy and expensive debt is already sitting on the balance sheet. -Current liabilities are increasing every quarter. -High short interest and analysts dropped their price targets.
0 · Reply
JarvisFlow
JarvisFlow Aug. 6 at 6:13 PM
Canaccord Genuity updates rating for Neuronetics ( $STIM ) to Buy, target set at 8 → 7.
0 · Reply
Shlobby
Shlobby Aug. 5 at 4:13 PM
Missed $UMAC this morning the. Caught dip at 10.30. Full position now. Cut a few $LC $STIM. Also added $GOGL
0 · Reply
HaltTradeAlert
HaltTradeAlert Aug. 5 at 3:35 PM
$STIM Halt Time: 11:33:54 Issue Symbol: STIM Reason Code: LUDP Members get this halt alert with no delay and with more info: last stock price, volume, shares outstanding, market cap, relative volume, and percentage change on the day. Also, halt alerts for pre-market hours and after market hours which is extremely important for Code T1 News Pending Alerts!! And free real time news catalyst alerts!
0 · Reply
_www_larval_com_
_www_larval_com_ Aug. 5 at 3:32 PM
$STIM has reverted 4% higher to -8% (~2Mv) in the last few minutes, 08/15 options, follow for more volatility.
0 · Reply
Shlobby
Shlobby Jul. 30 at 1:48 PM
Also opened $STIM
0 · Reply
dln101
dln101 Jul. 24 at 12:26 PM
$CLGN slow and steady back above $4-5, similar to $IRBT $STIM $ALDX $SATL 🤔💪🔥🚀
0 · Reply
PhaseFlow
PhaseFlow Jul. 23 at 3:22 AM
$STIM Looking for $4.75-5.00. If it makes it to $5 and breaks above then nothing to stop it until $7.00 Short term looking for about 15% move on this
0 · Reply
vjtweet
vjtweet Jul. 22 at 9:58 PM
$STIM holding a position for couple of days. Survived market shake outs in last few days.
0 · Reply
BigSqueezeComing
BigSqueezeComing Jul. 22 at 1:22 AM
$STIM Very bullish. PT 5
0 · Reply
SellHoldBuy
SellHoldBuy Jul. 15 at 12:38 PM
$STIM New cfo has to be a positive! Can hopefully help them get to healthy positive cash flow. I believe this was a necessary move.
0 · Reply
swingingtech
swingingtech Jun. 20 at 1:46 AM
$STIM https://wallstreetwaves.com/neuronetics-inc-offers-inducement-awards-to-new-hire-in-compensation-strategy/
0 · Reply
PenkeTrading
PenkeTrading Jun. 19 at 2:46 PM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of Neuronetics Inc. Is that bullish or bearish? $STIM #Neuronetics #RsiOversold #NASDAQ
0 · Reply
DonCorleone77
DonCorleone77 Jun. 2 at 11:03 PM
$CRDO $MLTX $STIM $TRVI $KURA Feel free to follow me for pre-market and after-hours movers every day. AFTER-HOURS MOVERS: Currently Higher After Earnings: -- Credo Technology (CRDO) up 12.4% Currently Also Higher: -- MoonLake Immunotherapeutics (MLTX) up 24.9% after FT report of potential $3B+ buyout offer from Merck (MRK) -- Neuronetics (STIM) up 7.4% after being included in Russell 2000, Russell 3000 Indexes -- Kura Oncology (KURA) up 1.4% after it declares 'positive' results from KOMET-001 Phase 2 trial of ziftomenib Currently Lower: -- Trevi Therapeutics (TRVI) down 3.2% after equity offering -- Parsons (PSN) down 4.3% after cutting guidance ahead of Baird conference
0 · Reply
DonCorleone77
DonCorleone77 Jun. 2 at 8:36 PM
$STIM Neuronetics set to join Russell 2000, Russell 3000 Indexes Neuronetics announced that it is set to join the broad-market Russell 3000 Index and the small-cap Russell 2000 Index at the conclusion of the Russell indexes annual reconstitution, effective after the US market opens on June 30.
0 · Reply
HMTRTN
HMTRTN May. 28 at 11:37 PM
$STIM $5+ price target!
0 · Reply
SellHoldBuy
SellHoldBuy May. 12 at 3:11 PM
$STIM Buying opportunity!!!!
1 · Reply
SellHoldBuy
SellHoldBuy May. 8 at 2:31 PM
$STIM Here we go!
0 · Reply
SellHoldBuy
SellHoldBuy May. 6 at 7:42 PM
$STIM nice to see it come back from those lows today but man they need to prove stability now . Cant go backwards and going through cash like water
0 · Reply
_www_larval_com_
_www_larval_com_ May. 6 at 5:02 PM
$STIM has slipped -3% lower to -13% (~2Mv) a moment ago, 05/16 options, follow for more volatility.
0 · Reply